These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 1663723)
21. The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein. Jinno H; Ueda M; Ozawa S; Ikeda T; Kitajima M; Maeda T; Seno M Anticancer Res; 2002; 22(6C):4141-5. PubMed ID: 12553045 [TBL] [Abstract][Full Text] [Related]
22. [The use of continuous cell cultures for the study of tumor heterogeneity and drug sensitivity]. Del Bufalo D; Cucco C; Leonetti C Medicina (Firenze); 1990; 10(3):298-302. PubMed ID: 1964194 [TBL] [Abstract][Full Text] [Related]
23. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813 [TBL] [Abstract][Full Text] [Related]
24. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Schluep T; Hwang J; Cheng J; Heidel JD; Bartlett DW; Hollister B; Davis ME Clin Cancer Res; 2006 Mar; 12(5):1606-14. PubMed ID: 16533788 [TBL] [Abstract][Full Text] [Related]
25. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines. Ali MA; Rosati R; Pettit GR; Kalemkerian GP Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758 [TBL] [Abstract][Full Text] [Related]
26. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma. Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488 [TBL] [Abstract][Full Text] [Related]
27. Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity. Rodrigues PC; Roth T; Fiebig HH; Unger C; Mülhaupt R; Kratz F Bioorg Med Chem; 2006 Jun; 14(12):4110-7. PubMed ID: 16546396 [TBL] [Abstract][Full Text] [Related]
28. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells. Sadava D; Phillips T; Lin C; Kane SE Cancer Lett; 2002 May; 179(2):151-6. PubMed ID: 11888669 [TBL] [Abstract][Full Text] [Related]
29. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533 [TBL] [Abstract][Full Text] [Related]
30. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing. Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744 [TBL] [Abstract][Full Text] [Related]
31. Expression of antigens associated with small cell carcinoma of the lung on hematopoietic progenitor cells. Ball ED; Keefe KA; Colby E Cancer Res; 1987 Dec; 47(24 Pt 1):6556-9. PubMed ID: 2824035 [TBL] [Abstract][Full Text] [Related]
32. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro. Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053 [TBL] [Abstract][Full Text] [Related]
33. Combinations of paclitaxel and etoposide in the treatment of lung cancer. Perez EA; Buckwalter CA; Reid JP Semin Oncol; 1996 Dec; 23(6 Suppl 15):21-5. PubMed ID: 8996593 [TBL] [Abstract][Full Text] [Related]
34. Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells. Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Tanimoto M Oncol Rep; 2006 Mar; 15(3):571-6. PubMed ID: 16465414 [TBL] [Abstract][Full Text] [Related]
35. Chemosensitivity test for human small cell lung cancer cell lines in vitro. Takahashi H; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sano T; Nakano H; Nakagawa K; Sakurai M Jpn J Clin Oncol; 1986 Sep; 16(3):253-60. PubMed ID: 3022034 [TBL] [Abstract][Full Text] [Related]
36. In vitro cytotoxicity of paclitaxel-transferrin conjugate on H69 cells. Bicamumpaka C; Pagé M Oncol Rep; 1998; 5(6):1381-3. PubMed ID: 9769372 [TBL] [Abstract][Full Text] [Related]
37. Somatostatin analogues and small-cell lung carcinoma. Taylor JE Recent Results Cancer Res; 1993; 129():71-82. PubMed ID: 8102490 [No Abstract] [Full Text] [Related]
38. Cytotoxic activity of daunorubicin or vindesin conjugated to a monoclonal antibody on cultured MCF-7 breast carcinoma cells. Aboud-Pirak E; Lesur B; Rao KS; Baurain R; Trouet A; Schneider YJ Biochem Pharmacol; 1989 Feb; 38(4):641-8. PubMed ID: 2917019 [TBL] [Abstract][Full Text] [Related]
39. Evidence in support of the plasma membrane as the target for transferrin-adriamycin conjugates in K562 cells. Barabas K; Sizensky JA; Faulk WP Am J Reprod Immunol; 1991 Apr; 25(3):120-3. PubMed ID: 1930638 [TBL] [Abstract][Full Text] [Related]
40. A novel antitumor antibiotic, KW-2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells. Ogasawara H; Nishio K; Takeda Y; Ohmori T; Kubota N; Funayama Y; Ohira T; Kuraishi Y; Isogai Y; Saijo N Jpn J Cancer Res; 1994 Apr; 85(4):418-25. PubMed ID: 8200853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]